Question 1

What is Stargardt Disease?

Accepted Answer

Stargardt disease, also known as Stargardt macular dystrophy, is a rare, inherited eye disorder that primarily affects the macula, the central part of the retina responsible for sharp, detailed vision.

Question 2

What is the Stargardt Disease Market outlook in the 7MM?

Accepted Answer

In 2023, the total Stargardt Disease market size in the 7MM was USD 27 million, which is expected to increase by 2034.

Question 3

Which country dominates the Stargardt Disease Market?

Accepted Answer

Among the 7MM, the United States accounted for the highest market size, followed by Japan.

Question 4

Is the Stargardt Disease market expecting any changes during the forecast period, and what will likely be the key factors?

Accepted Answer

Yes, the Stargardt Disease market is anticipated to evolve owing to the increasing prevalence, growing awareness of Stargardt Disease, and the expected launch of emerging drugs.

Question 5

Which country exhibits the highest prevalence of Stargardt Disease cases among the 7MM?

Accepted Answer

Among the 7MM, the United States accounted for the highest number of diagnosed prevalent cases of Stargardt Disease.

Question 6

Which are the leading Stargardt Disease Companies in the market?

Accepted Answer

Some of the leading players in the Stargardt Disease Market include RBP4 Pty Ltd, Belite Bio, Kubota Vision, Ocugen, Nanoscope Therapeutics, Stargazer Pharmaceuticals, Iveric Bio, Sanofi, Alkeus Pharmaceuticals, Astellas Pharma, and others.